Biofiller is an autologous injectable treatment prepared from the patient’s own blood and used for selected applications of volume restoration and skin rejuvenation.
Unlike conventional synthetic fillers, Biofiller is based on autologous plasma, which is processed into a gel-like form so that it can provide gentle tissue support.
Depending on the protocol, Biofiller may be used to help improve:
Its key characteristic is that the material comes from the patient’s own body.
The goal is not excessive filling. The goal is natural volume restoration combined with gradual improvement in tissue quality.
The term Biofiller is used for autologous injectable materials derived from the patient’s own blood.
Depending on the treatment protocol, it may be prepared from:
Through controlled processing, part of the plasma is transformed into a gel with greater consistency and volume.
This gel can then be injected into selected areas.
Biofiller is autologous, meaning that it is derived from the patient’s own blood.
This means that a conventional foreign volumising filler is not used as the main injectable material.
For patients seeking a more biological approach, this can be an important advantage.
The exact composition and characteristics depend on the preparation protocol used.
Biofiller may have two main roles.
1. Volume Restoration
The gel form of autologous plasma may provide support in areas of mild volume loss.
This may help improve:
2. Biostimulation
Depending on the preparation method, the autologous material may contain platelets and growth factors involved in tissue-repair and regenerative processes.
This may help support:
Depending on anatomy and indication, Biofiller may be used in areas such as:
Not every area is suitable for Biofiller.
The choice depends on the type of correction required.
The under-eye area is one of the more popular applications of autologous plasma gels.
In appropriately selected patients, Biofiller may be used for:
It is not suitable for every under-eye concern.
When there is:
another treatment such as Thermi-Lid™, lower blepharoplasty or a different technique may be more appropriate.
In the face, Biofiller may be used for selected applications of natural tissue support and rejuvenation.
It may help improve:
The result is generally more subtle than that produced by a high-density structural filler.
In the neck and décolletage, the goal is usually more about skin quality than significant volume enhancement.
Biofiller may be used to support:
With age, the back of the hands may develop:
In selected patients, Biofiller or other autologous techniques may be considered for gentle rejuvenation and tissue support.
Autologous plasma gels may also be used in selected cases of atrophic scarring.
The goals may include:
For more significant scars, a combination approach may be required, such as:
They are not the same.
PRP is primarily used as a more fluid autologous preparation for biostimulation and skin rejuvenation.
Biofiller is processed into a thicker gel form and can provide a greater filling or tissue-support effect.
In selected protocols, the two may be combined.
PRF is produced through a different blood-processing protocol.
It may be used in liquid form or prepared as a gel.
PRF gel is increasingly used as an autologous option in areas where mild volume restoration and biological tissue support are desired.
The choice between Biofiller, PRP and PRF depends on:
The two treatments have different strengths.
Potential advantages:
Limitations:
Potential advantages:
The correct choice depends on the result we want to achieve.
Not necessarily.
Being autologous is an important advantage for some patients.
However, this does not automatically make Biofiller superior to every other injectable option.
For one patient, it may be ideal.
For another, it may not provide enough support or projection.
The goal is to select the most appropriate material for the patient’s anatomy and treatment objective.
The procedure generally involves:
The exact technique and preparation time depend on the protocol used.
The total treatment time depends on:
The full procedure is usually completed during the same visit.
An initial filling effect may be visible immediately.
However, the appearance may change as:
Skin-quality improvement is usually more gradual.
There is no single duration that applies to every patient.
Results depend on:
It is more appropriate to consider Biofiller a temporary autologous treatment rather than promise a fixed long-term duration for every patient.
The number of treatments is personalised.
In some patients, the plan may include:
Other protocols may involve a series of treatments.
Downtime is usually limited.
After treatment, temporary effects may include:
Most patients return relatively quickly to their normal daily activities.
Because the material is derived from the patient’s own blood, the risk of reaction to a foreign filler material is reduced.
However, it remains a medical injectable procedure and is not completely risk-free.
Possible complications may include:
Safety depends on:
Yes.
Biofiller may be incorporated into a wider skin-rejuvenation or regenerative treatment plan.
Depending on the indication, it may be combined with:
Combination treatment is used only when the procedures have complementary roles.
A combined approach may be useful when the goals include both:
The exact combination depends on the treatment protocol.
In patients with:
Fractional RF may be used as a complementary treatment to stimulate collagen remodelling.
When the patient also has:
Pico Laser or another suitable laser treatment may be combined with Biofiller.
Biofiller focuses more on tissue quality and mild volume support, while laser treatments target different aspects of the skin.
Biofiller should not be used as a “natural filler for everyone”.
Correct treatment requires an understanding of:
Dr Andreas Ioannides, Plastic, Aesthetic & Reconstructive Surgeon, assesses whether the best option is:
The goal is not simply to choose the most “natural” material. The goal is to choose the right material for the right result.
Biofiller may be suitable for women and men who:
It may not provide sufficient correction when the patient requires:
In these cases, another injectable or surgical approach may be more appropriate.
The cost varies according to the personalised treatment plan.
The final price depends on:
The exact price is determined after a personal consultation.
Biofiller may be an interesting option for patients looking for:
The goal is to support your tissues — not change your facial identity.
During your personal consultation, Dr Andreas Ioannides will assess:
The most appropriate approach may then include:
Biofiller, PRP, PRF, nanofat, Fractional RF, Pico Laser or a combination of techniques.
Biofiller is an autologous injectable gel prepared from components of the patient’s own blood and used for subtle volume restoration and rejuvenation.
It is autologous because it is derived from the patient’s own blood.
No. PRP is mainly a fluid biostimulatory preparation, while Biofiller has a gel consistency and can provide more of a filling effect.
Not exactly. PRF is produced using a different processing protocol and may also be prepared in gel form.
In appropriately selected patients, it may be used for mild tear trough hollowing and under-eye rejuvenation.
Not in every case. Hyaluronic acid can provide more predictable structural support and contouring.
An initial filling effect may be visible immediately, while improvements in skin quality develop more gradually.
Duration varies according to the protocol, treatment area and individual response.
This is personalised. Some patients may have one initial treatment followed by reassessment, while others may benefit from more than one session.
Usually limited. Temporary swelling, redness or bruising may occur.
It is autologous, but it remains a medical injectable procedure and can still carry risks.
Yes. In selected protocols, combinations may be used for broader regenerative support.
The cost depends on the treatment area, preparation protocol, amount of material and any combination treatments.